Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
03/2004
03/25/2004WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same
03/25/2004WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
03/25/2004US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
03/25/2004US20040058936 Dietetics, sexual disorders, antidiabetic agents
03/25/2004CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
03/24/2004EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
03/24/2004EP1399146A1 Novel compounds and compositions as cathepsin inhibitors
03/24/2004EP0904079B1 Antidiabetic agents
03/24/2004CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same
03/18/2004WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
03/18/2004US20040053961 Excitatory amino acid receptor antagonists
03/18/2004US20040053960 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053932 Peptide deformylase inhibtors
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053890 Naphthalene derivatives
03/17/2004EP1397350A1 Isoquinolinone derivatives as parp inhibitors
03/17/2004EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004CN1483033A Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/11/2004WO2004005279A3 Substituted anthranilic amide derivatives and methods of use
03/11/2004WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators
03/11/2004US20040048904 E.g., 1-(pyridin-4-ylcarbamoyl)-1,2,3,6- tetrahydropyridine hydrochloride; treating and/or preventing amnesia or dementia
03/11/2004US20040048797 Regulation of TNF-alpha
03/11/2004DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders
03/10/2004EP1396488A1 Fused heterocyclic compound and medicinal use thereof
03/10/2004EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
03/09/2004US6703405 Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
03/09/2004US6703403 Method for improving pharmacokinetics
03/09/2004US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment
03/09/2004US6703391 Quinoxalinedione derivatives, their preparation and use
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2003088917A3 Regulation of tnf-alpha
03/04/2004WO2003040402A3 Alpha-helix mimicry by a class of organic molecules
03/04/2004US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors
03/04/2004US20040044211 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
03/04/2004US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders
03/04/2004US20040044031 Controlling appetite; dietetics; sleep disorders
03/04/2004US20040044030 Cardiovascular disorders; antiarrhythmia agents
03/04/2004US20040044000 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders
03/03/2004EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators
03/03/2004EP1392639A1 Pyruvate derivatives
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1392363A2 Compositions and uses of mglur5 antagonists
03/03/2004EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
03/03/2004EP1392280A2 Arylsulfonamide ethers, and methods of use thereof
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699651 Base precursors for use in a photothermographic element
02/2004
02/26/2004WO2004016583A1 Substituted glycine derivatives for use as medicaments
02/26/2004WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv
02/26/2004US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc.
02/26/2004US20040038959 Treating osteoarthritis or rheumatoid arthritis
02/26/2004US20040037022 Aminoalcohol derivatives
02/26/2004CA2494546A1 Substituted glycine derivatives for use as medicaments
02/25/2004EP1200409B1 Substituted isoquinoline derivatives and their use as anticonvulsants
02/25/2004EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004EP0984967B1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus
02/25/2004CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis
02/25/2004CN1477100A Compound with activity for resisting platelet agregation and its preparation method
02/25/2004CN1139576C Process for preparation of optically active (R)-or (S)-1-(4-methoxy-benzyl)-8-octahydro-isoquinoline
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure
02/19/2004WO2004014871A1 Vanilloid receptor ligands and their use in treatments
02/19/2004WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
02/19/2004WO2004014378A1 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors
02/19/2004WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
02/19/2004US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same
02/19/2004US20040034056 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
02/19/2004US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme
02/19/2004CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
02/18/2004EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors
02/18/2004EP1389194A2 Inhibitors of bace
02/18/2004EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
02/18/2004CN1476436A Novel compounds for use as HIV protease inhibitors
02/18/2004CN1476424A 萘衍生物 Naphthalene Derivatives
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
02/12/2004WO2003062261A3 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004US20040030131 Central nervous system disorders
02/12/2004US20040029898 Anticancer agents
02/12/2004US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders
02/12/2004US20040029880 Anthranyl amides and their use as medicaments
02/11/2004EP1387839A1 Process for the production of quinazolines
02/11/2004EP1224177B1 Process for preparing oxazolines from tetrahydrofurans
02/11/2004CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor
02/05/2004WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
02/05/2004US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
02/05/2004US20040024210 New compounds
02/05/2004US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/04/2004EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
02/04/2004EP1385823A1 Novel guanidino compounds
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 119